Klaviyo Acquires AI Customer Success Startup Agency, Reunites With Former Mentor Elias Torres

Klaviyo, the publicly traded e-commerce marketing automation platform, has agreed to acquire Agency, a three-year-old AI-powered customer success startup founded by Elias Torres, in a deal with undisclosed financial terms. Agency had previously raised $32 million from investors including Sequoia, Menlo Ventures, and Felicis.

As part of the acquisition, Torres will join Klaviyo as chief product officer, leading Agency’s 25-person team to help expand Klaviyo’s AI agent offerings, including Composer, which builds marketing campaigns, and Customer Agent, which manages post-sale support tasks like returns and order tracking. Klaviyo co-founder and CEO Andrew Bialeckisaid the goal is to bring the combined AI capabilities to Klaviyo’s roughly 200,000 business customers and expand further in coming years.

The deal marks a reunion between Torres and Bialecki, who first worked together in 2010 when Torres hired Bialecki as an early engineer at his startup Performable, later acquired by HubSpot. Torres went on to co-found Drift, which sold to Vista Equity for $1.2 billion in 2021, while Bialecki founded Klaviyo shortly after leaving Performable, with Torres later investing as an early backer. Klaviyo went public in 2023 at a $9.2 billion valuation. Bialecki said the partnership positions Klaviyo to compete with AI agent rivals like Decagon and Sierra by leveraging its extensive customer data.

Featured image: Credit: Klaviyo

Need Deeper Intelligence on the AI Market?

AI Insider's Market Intelligence platform tracks funding rounds, competitive landscapes, and technology trends across the global AI ecosystem in real time. Get the data and insights your organization needs to make informed decisions.

Related Articles

Jaipur Robotics Raises €4.3M in Seed Funding to Expand AI Platform for Waste-to-Energy Plants

Insider Brief Jaipur Robotics has raised €4.3 million in seed funding led by EquityPitcher Ventures and High-Tech Gründerfonds to expand its AI and automation platform

AI-Designed Drug Shows Signs of Lowering Biological Age in Early Clinical Study

Insider Brief An artificial intelligence-designed drug for a deadly lung disease produced protein changes associated with lower biological age, offering early evidence that AI-discovered medicines

HiddenLayer Announces $100M Series B as AI Security Market Surges

AI security startup HiddenLayer has raised $100 million in a Series B round led by Delta-v Capital, with participation from Ten Eleven Ventures, Morgan Stanley,

Stay Updated with AI Insider

Get the latest AI funding news, market intelligence, and industry insights delivered to your inbox weekly.

$ 0 M

Seed round tracked

Gitar — Code Validation

Get the Weekly Briefing

Funding analysis, market intelligence, and industry trends delivered to your inbox every week.

Need bespoke intelligence?

Our team combines real-time data with decades of sector experience to guide your decisions.

Subscribe today for the latest news about the AI landscape